Lord Stevens
Dr Angela Gallop
Chris Gregg QPM
Dr Jonathan K C Knowles
Key members of the Axiom team
An unparalleled combination of policing and forensic science skill and expertise
Lord Stevens Kt;QPM;DL;LLD
Executive Chairman
Lord Stevens is the most respected Metropolitan Police Commissioner in modern
times and has succeeded in making profound changes and garnered support from
all sections of the community.
During his career, he led many high profile investigations, including the alleged collusion between the security Forces and Paramilitaries in Northern Ireland, and more recently, the Metropolitan Police investigation into the allegation of conspiracy to murder Diana, Princess of Wales and Dodi Al-Fayed.
Amongst many academic and other honours, in 1991 Lord Stevens was awarded the Queen’s Police Medal for distinguished service. He was made Deputy Lieutenant of London in 2001 and a Knight of St John, and received the Freedom of the City of London in 2002. He was then awarded a life peerage on his final day with the Police in 2005 and sits as an independent peer in the House of Lords. He was appointed by Prime Minister Gordon Brown as Senior Advisor on International Security issues and also chaired the Board of Policing Committee for David Cameron, Leader of the Conservative Party.
For three years he has chaired
the Strategy Advisory Panel at Interpol.
» Back to top
Dr Angela Gallop
Chief Executive and Forensic Science Director
Angela Gallop is one of the UK's most eminent forensic scientists, recognised
equally for her skill in leading complex investigations and for setting up
and running full scale forensic science laboratories.
Angela's career began 36 years ago with the Home Office Forensic Science Service specialising in the investigation of crimes of violence. She established influential independent forensic science consultancy, Forensic Access and in 1997 co-founded Forensic Alliance - the first non-Government laboratory to provide full forensic services to police investigators. In 2005, Angela facilitated the acquisition of Forensic Alliance by LGC (The Laboratory of The Government Chemist). This significantly extended the range of science and innovation available to forensic science, contributing to the successful solving of some particularly complex cases such as The Cardiff Three, Damilola Taylor and Rachel Nickell.
Angela is a Past President of the Forensic Science Society and was a founding
member of the Governing Council for the Registration of Forensic Practitioners.
» Back to top
Chris Gregg QPM
Policing Director
Chris Gregg is one of the UK's most distinguished detectives, recently described
by Chief Constable, Sir Norman Bettison, as "one of the finest senior detectives
the Force had ever known."
Chris served 32 years with the Police Service in the United Kingdom, leaving in 2008. As Detective Chief Superintendent, he set up and led West Yorkshire Police's highliy acclaimed Homicide and Major Enquiry Team (HMET). During his career Chris headed up many of the country’s most high profile criminal investigations. These included the capture of American fugitive David Bieber, the kidnap and murder of Leeds schoolgirl Leanne Tiernan, solving the twenty five year Yorkshire Ripper hoaxer mystery, and the conviction of serial killer nurse Colin Norris. He also led the enquiry into the murders carried out by serial killer Dr Harold Shipman in Yorkshire.
Chris was awarded the Queen's Police Medal for distinguished service in the
2008 Queen’s Birthday Honours. He has since worked as Specialist Police Advisor
for LGC Forensics, involved in international business development.
» Back to top
Dr Jonathan K C Knowles
Jonathan Knowles was Head of Group Research and Member of the Executive Committee at Roche up to the end of 2009. He was a member of the Genentech Board for the last 12 years and a member of the Chugai Board for seven years. Jonathan was also Chairman of the Corporate Governance Committee of Genentech. He focused the company on key disease biology areas of high medical need and in-depth understanding of molecular pathology of disease. Under his leadership, the company developed and implemented a strategy of highly effective therapies based on personalized healthcare through integration with molecular diagnostics and built one of the best pipelines in the sector.
Jonathan was for 5 years the Chairman of the Research Directors’ Group of EFPIA (European Federation of Pharmaceutical Industry Associations) and was the first chairman of the Board of the Innovative Medicines Initiative, a unique public-private partnership between 28 Pharmaceutical companies and the European Commission with a budget of more than 2 Billion Euros over five years.
Jonathan holds a Distinguished Professorship in Personalized medicine at FIMM (Institute for Molecular Medicine Finland) at the University of Helsinki, was recently appointed Professor of Translational Research at EPFL in Switzerland and has been appointed to a Visiting chair at the University of Oxford. In addition, he is a Member of the European MolecularBiology Organization and a Visiting Fellow of Pembroke College Cambridge. He is also a Member of EMBO.
Jonathan Knowles attended Magdalen College School in Oxford and received a First Class Honours Degree in Molecular Genetics from the University of East Anglia in Norwich, England. He received his Ph.D. in Genetics of Mitochondria with Professor G. H. Beale F.R.S. from the University of Edinburgh in Scotland.
From the beginning of 2010, Jonathan joined the Board of Caris Life Sciences, an international cutting edge molecular diagnostics Company based in Irving, Texas. Caris is focused on the development of revolutionary new blood baseddiagnostics for cancer and other serious diseases.
In 2011, Jonathan Knowles was appointed as a Trustee of Cancer Research UK, one of the world’s leading Cancer Research organisations.




